Syneron to Present at Four Investor Conferences in September 2006

Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, announced today that it will be presenting at four investor conferences in September 2006.

--  On Thursday, September 7, 2006, Syneron CFO David Seligman will
    present at the Thomas Weisel Partners Healthcare Conference in Boston.
--  On Monday, September 18, 2006, Syneron CEO David Schlachet, will
    present in San Francisco at the Merriman Curhan Ford Annual Investor
--  Mr. Schlachet will participate in the Sterne Agee Best Ideas
    Conference in Milwaukee on Tuesday, September 19, 2006.
--  Chairman and co-founder of Syneron, Shimon Eckhouse, will present at
    the UBS Global Life Sciences Conference in New York on September 25-28.

The date and times of all the presentation will be posted in the "For Investor" section of the Syneron website, Where Syneron management is making a formal presentation, the presentation will be broadcast live over the Internet. The web casts can be accessed through the investor section on the Syneron's web site. Please go to the web site a few minutes early, as it may be necessary to download audio software to hear the presentation.

About Syneron

Syneron Medical Ltd. (NASDAQ: ELOS) develops, manufactures and distributes medical aesthetic devices that are powered by elos, the combined-energy technology of bi-polar radio frequency and light. The company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American Headquarters in Canada, European Headquarters in Germany, and Asia-Pacific Headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at

Syneron, the Syneron logo, and elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. Elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here